Fair point, particularly that this report was complied at Arborgen's request. But the projections on earnings growth do mirror my own analysis. I see that KPMG have also been hired to do a strategic review. Let's see what they have to say.
Printable View
Fair point, particularly that this report was complied at Arborgen's request. But the projections on earnings growth do mirror my own analysis. I see that KPMG have also been hired to do a strategic review. Let's see what they have to say.
Edison had a $0.74 valuation on ARB a few years ago
'Allbirds is set to follow Rocket Lab and become the second company founded by a Kiwi to line up a multi-billion Nasdaq listing this year.'......surely the timing must be right for ARB?
It has been 3 months since Arborgen announced a strategic review triggered by a conditional offer to buy the company. I wish shareholders like myself had pushed harder during the annual meeting for some clarity on when this review will be complete, and how long the company has to provide a definitive response to the offer if they haven't already made one.
For the benefit of long suffering shareholders, the strategic review should include an update of slides 15-21 from the ArborGen Opportunity presentation from June 2018. That will give us some confidence that the proposed buyout did in fact "materially undervalue" the company.
Details of the US listing opportunity should be provided too.
almost hopefully coming up 3 months of accelerated growth .. and SP is retreating ..
I dont get it .. Is the Mic upstairs from the Northern hemisphere not working now
or is everyone upstairs busy outside putting out bush fires ? ;)